Luna Group Listed by lamashtu Ransomware Group: Ransomware Claim — What’s Alleged & What To Do

On May 4, 2026, the lamashtu ransomware group listed Luna Group on its public leak site and claimed responsibility for a ransomware attack that included the exfiltration of internal files. The number of people whose data may be affected is not known, and no further details about the timing or scope of the incident have been released by either the organisation or the group. The listing marks the first public indication that Luna Group’s systems were targeted. No confirmation of the attack has been issued by the company, and the precise date of any intrusion or the volume of data involved remain undisclosed.

Inside the incident

The only confirmed information is the May 2026 listing itself. The group states that internal files were taken during a ransomware operation. No ransom demand amount, encryption details, or evidence of data publication has been made public. Organisations in similar situations often conduct their own forensic reviews before issuing statements, which can delay further disclosures.

Who is lamashtu?

Lamashtu is a ransomware operator that follows the common pattern of encrypting victim systems and threatening to release stolen data. Like other groups in this category, it maintains a leak site where it lists organisations it claims to have compromised, using the public posting as leverage in ransom negotiations. Its prior activity has followed the double-extortion model seen across multiple ransomware campaigns since 2020.

About Luna Group

Luna Group is an Egyptian conglomerate founded in 1966 with operations across the Middle East and North Africa. Its main activities are in pharmaceuticals, cosmetics, perfumes, and industrial raw materials. Companies of this scale routinely maintain records related to manufacturing processes, regulatory submissions, supply-chain contracts, and employee or partner information.

The information in question

The listing refers only to “internal files exfiltrated in ransomware attack.” The exact categories of data have not been disclosed. Organisations in the pharmaceutical and cosmetics sectors typically hold formulation records, clinical or stability data, distribution agreements, and personnel files, but whether any of these specific types were taken in this case is unconfirmed.

What's at stake

Exposure of internal files from a regional pharmaceutical and manufacturing operator can affect competitive information, regulatory compliance records, and operational continuity. For individuals whose details appear in such files, the primary concerns are potential misuse of contact or employment data and secondary targeting through phishing. The organisation faces possible regulatory scrutiny under data-protection or sector-specific rules in the countries where it operates.

Were you affected?

Individuals can begin by monitoring official statements from Luna Group and checking whether their email address appears in any publicly indexed breach repositories. Running a free exposure scan of an email address against known breach data provides one initial indicator. If personal information is believed to may have been exposed, standard steps include changing associated passwords, enabling multi-factor authentication, and reviewing financial or medical accounts for unusual activity.

AICompiled with AI assistance from public sources and published under our editorial standards.